McClung David 4
4 · BioCardia, Inc. · Filed May 22, 2023
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
McClung David
Chief Financial Officer
Transactions
- Award
Common Stock
2023-05-18$1.70/sh+61,389$104,361→ 152,120 total - Award
Stock Option (right to buy)
2023-05-18+68,265→ 68,265 totalExercise: $1.70Exp: 2033-05-18→ Common Stock (68,265 underlying)
Footnotes (2)
- [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on May 18, 2023.
- [F2]The option vests and becomes exercisable as to 1/48th of the shares on June 18, 2023, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.